Quantitative differences between aberrant transcripts which occur as common isoforms and due to mutation-based exon skipping of the mismatch repair gene hMLH1

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 9, 1999, Pages 883-887

  Plaschke, Jens ^b   Bulitta, Clemens ^a   Saeger, Hans D ^c   Schackert, Hans K ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c NONE

Author keywords

Aberrant transcripts; cDNA; hMLH1; HNPCC; RT PCR

Indexed keywords

COMPLEMENTARY DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BASE PAIR MISMATCH; CARRIER PROTEINS; CHILD; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; EXONS; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 0032747819     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.131     Document Type: Article

References (21)

1. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch PM, Cavalieri RJ, et al. Genetics, natural history, tumour spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104:1535-49.
2. Papadopoulos N, Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mut 1997; 10:89-99.
3. Peltomäki P, Vasen HFA and The International Collaborative Group On Hereditary Nonpolyposis Colorectal Cancer. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 1997; 113:1146-58.
4. Nyström-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995; 1:1203-6.
5. Mauillon JL, Michel P, Limacher JM, Latouche JB, Dechelotte P, Charbonnier F, et al. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res 1996; 56:5728-33.
6. Maquat, LE. When cells stop making sense: effects of non-sense codons on RNA metabolism in vertebrate cells. RNA 1995; 1:453-65.
7. Charbonnier F, Martin C, Scotte M, Sibert L, Moreau V, Freybourg T. Alternative splicing of MLH1 messenger RNA in human normal cells. Cancer Res 1995; 55:1839-41.
8. Xia L, Shen W, Ritacca F, Mitri A, Madlensky L, Berk T, et al. A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. Cancer Res 1996; 56:2289-92.
9. Kohonen-Corish M, Ross VL, Doe WF, Kool DA, Edkins E, Faragher I, et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet 1996; 59:818-24.
10. Mori Y, Shiwaku H, Fukushige S, Wakatsuki S, Sato M, Nukiwa T, et al. Alternative splicing of hMSH2 in normal tissues. Hum Genet 1997; 99:590-5.
11. Genuardi M, Viel A, Bonora B, Capozzi E, Bellacosa A, Leonardi F, et al. Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Hum Genet 1998; 102:15-20.
12. Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MRS, Morrison P, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 1994; 24:516-26.
13. Kolodner RD, Hall NR, Lipford J, Kane MF, Morrison PT, Finan PJ, et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res 1995; 55:242-8.
14. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9:48-55.
15. Wong H, Anderson WD, Cheng T, Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: The iprimer-droppingi method. Anal Biochem 1994; 223:251-8.
16. Padgett RA, Grabowski PJ, Konarska MM, Seiler S, Sharp PA. Splicing of messenger RNA precursors. Annu Rev Biochem 1986; 55:1119-50.
17. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90:41-54.
18. Wijnen J, Khan PM, Vasen H, Menko F, van der Klift H, van den Broek M, et al. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet 1996; 58:300-7.
19. Palmirotta R, Veri MC, Curia MC, Aceto G, D'Amico F, Esposito DL, et al. Transcripts with splicing of exons 15 and 16 of the hMLH1 gene in normal lymphocytes: implications in RNA-based mutation screening of hereditary non-polyposis colorectal cancer. Eur J Cancer 1998; 34:927-30.
20. Viel A, Genuardi M, Capozzi E, Leonardi F, Bellacosa A, Paravatou-Petsotas M, et al. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary non-polyposis colorectal cancer. Genes Chromosomes Cancer 1997; 18:8-18.
21. Andreutti-Zaugg C, Scott RJ, Iggo R. Inhibition of non-sense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques. Cancer Res 1997; 57:3288-93.